Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.49−0.50 (-2.78%)
Close on Nov 13, 2026Market cap $1.27BP/E –Yield –
Omeros ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Omeros's ebitda for the twelve months ending Jun 30, 2026 was -$71.91M. For fiscal 2025 it was -$121.83M. The highest annual figure on record is -$20.31M in fiscal 2009.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$121.83M | – |
| FY2024 | Dec 31, 2024 | -$166.00M | – |
| FY2023 | Dec 31, 2023 | -$163.61M | – |
| FY2022 | Dec 31, 2022 | -$162.44M | – |
| FY2021 | Dec 31, 2021 | -$172.23M | – |
| FY2020 | Dec 31, 2020 | -$155.30M | – |
| FY2019 | Dec 31, 2019 | -$144.25M | – |
| FY2018 | Dec 31, 2018 | -$111.26M | – |
| FY2017 | Dec 31, 2017 | -$43.34M | – |
| FY2016 | Dec 31, 2016 | -$53.98M | – |
| FY2015 | Dec 31, 2015 | -$71.03M | – |
| FY2014 | Dec 31, 2014 | -$69.69M | – |
| FY2013 | Dec 31, 2013 | -$50.21M | – |
| FY2012 | Dec 31, 2012 | -$36.57M | – |
| FY2011 | Dec 31, 2011 | -$26.98M | – |
| FY2010 | Dec 31, 2010 | -$29.63M | – |
| FY2009 | Dec 31, 2009 | -$20.31M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $267.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.18M | – |
| Q4 FY2025 | Dec 31, 2025 | -$28.85M | – |
| Q3 FY2025 | Sep 30, 2025 | -$26.15M | – |
| Q2 FY2025 | Jun 30, 2025 | -$32.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$34.68M | – |
| Q4 FY2024 | Dec 31, 2024 | -$33.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$35.17M | – |
| Q2 FY2024 | Jun 30, 2024 | -$58.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$38.83M | – |
| Q4 FY2023 | Dec 31, 2023 | -$39.56M | – |
| Q3 FY2023 | Sep 30, 2023 | -$47.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$40.60M | – |
| Q1 FY2023 | Mar 31, 2023 | -$35.53M | – |
| Q4 FY2022 | Dec 31, 2022 | -$39.98M | – |
| Q3 FY2022 | Sep 30, 2022 | -$50.47M | – |
| Q2 FY2022 | Jun 30, 2022 | -$37.24M | – |
| Q1 FY2022 | Mar 31, 2022 | -$34.77M | – |
| Q4 FY2021 | Dec 31, 2021 | -$42.57M | – |
| Q1 FY2021 | Mar 31, 2021 | -$44.90M | – |
| Q4 FY2020 | Dec 31, 2020 | -$33.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$25.03M | – |
| Q2 FY2020 | Jun 30, 2020 | -$27.28M | – |
| Q1 FY2020 | Mar 31, 2020 | -$23.28M | – |
| Q4 FY2019 | Dec 31, 2019 | -$23.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.89M | – |
| Q1 FY2019 | Mar 31, 2019 | -$18.86M | – |
| Q4 FY2018 | Dec 31, 2018 | -$18.17M | – |
| Q3 FY2018 | Sep 30, 2018 | -$35.22M | – |
| Q2 FY2018 | Jun 30, 2018 | -$30.41M | – |
| Q1 FY2018 | Mar 31, 2018 | -$27.47M | – |
| Q4 FY2017 | Dec 31, 2017 | -$13.95M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.97M | – |
| Q2 FY2017 | Jun 30, 2017 | -$11.82M | – |
| Q1 FY2017 | Mar 31, 2017 | -$12.61M | – |
| Q4 FY2016 | Dec 31, 2016 | -$11.77M | – |
| Q3 FY2016 | Sep 30, 2016 | -$11.95M | – |
| Q2 FY2016 | Jun 30, 2016 | -$10.86M | – |
See a number that looks wrong?